搜索医生

Timothy R. Aksamit, M.D.

  1. Critical Care Specialist
  2. Internist
  3. Pulmonologist
预约门诊

出版物

  1. Aksamit TR, Locantore N, Addrizzo-Harris D, Ali J, Barker A, Basavaraj A, Behrman M, Brunton AE, Chalmers S, Choate R, Dean NC, DiMango A, Fraulino D, Johnson MM, Lapinel NC, Maselli DJ, McShane PJ, Metersky ML, Miller BE, Naureckas ET, O'Donnell AE, Olivier KN, Prusinowski E, Restrepo MI, Richards CJ, Rhyne G, Schmid A, Solomon GM, Tal-Singer R, Thomashow B, Tino G, Tsui K, Varghese SA, Warren HE, Winthrop K, Zha BS. Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients. Am J Respir Crit Care Med. 2024 Jul 1; 210 (1):108-118
    View PubMed
  2. Aksamit TR, Lapinel NC, Choate R, Feliciano J, Winthrop KL, Schmid A, Wu J, Fucile S, Metersky ML, Bronchiectasis and NTM Research Registry Investigators. Association between bronchiectasis exacerbations and longitudinal changes in FEV(1) in patients from the US bronchiectasis and NTM research registry. Respir Med. 2024 Jul; 228:107660 Epub 2024 May 09
    View PubMed
  3. McShane PJ, Brunton AE, Choate R, Marmor M, Richards CJ, Solomon GM, Maselli DJ, Swenson C, Aksamit TR, Metersky ML. The Impact of Tobacco Smoking in Bronchiectasis: Data from the U.S. Bronchiectasis and Nontuberculous Mycobacteria Research Registry. Am J Respir Crit Care Med 2024 Jul 1; 210 (1):128-130
    View PubMed
  4. Basavaraj A, Brunton AE, Choate R, Barker A, Jakharia K, Richards C, Swenson C, Aksamit TR, Metersky ML, Bronchiectasis and NTM research registry investigators.. Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM research registry. Respir Med Res. 2024 Apr 24; 86:101107 [Epub ahead of print]
    View PubMed
  5. Basavaraj A, Choate R, Becker BC, Aksamit TR, Metersky ML, Bronchiectasis and NTM Research Registry Investigators. Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM research registry. Respir Med. 2024 Mar; 223:107555 Epub 2024 Feb 01
    View PubMed
  6. Griffith DE, Aksamit TR. Diagnostic Criteria and the Decision to Treat Nontuberculous Mycobacterial Pulmonary Disease. Clin Chest Med. 2023 Dec; 44 (4):757-769 Epub 2023 Sept 01
    View PubMed
  7. Aksamit TR, Emery EJ, Basavaraj A, Metersky ML, O'Donnell AE, Addrizzo-Harris DJ. The 6th World Bronchiectasis and Nontuberculous Mycobacteria Conference Abstract Presentations. Chronic Obstr Pulm Dis. 2023 Oct 26; 10 (4):450-516
    View PubMed
  8. Diaz AA, Nardelli P, Wang W, San Jose Estepar R, Yen A, Kligerman S, Maselli DJ, Dolliver WR, Tsao A, Orejas JL, Aliberti S, Aksamit TR, Young KA, Kinney GL, Washko GR, Silverman EK, San Jose Estepar R. Artificial Intelligence-based CT Assessment of Bronchiectasis: The COPDGene Study. Radiology. 2023 Apr; 307 (1):e221109 Epub 2022 Dec 13
    View PubMed
  9. Asif H, Rahaghi FF, Ohsumi A, Philley J, Emtiazjoo A, Hirama T, Baker AW, Shu CC, Silveira F, Poulin V, Rizzuto P, Nagao M, Burgel PR, Hays S, Aksamit T, Kawasaki T, Dela Cruz C, Aliberti S, Nakajima T, Ruoss S, Marras TK, Snell GI, Winthrop K, Mirsaeidi M. Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi study. ERJ Open Res. 2023 Mar; 9 (2) Epub 2023 Mar 27
    View PubMed
  10. Ku JH, Henkle E, Aksamit TR, Barker A, Brunton AE, Winthrop KL, Bronchiectasis and NTM Research Registry investigators. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clin Infect Dis. 2023 Jan 13; 76 (2):338-341
    View PubMed
  11. Aksamit T, Wu J, Hassan M, Achter E, Chatterjee A. Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings. BMC Pulm Med. 2022 Dec 3; 22 (1):461 Epub 2022 Dec 03
    View PubMed
  12. Monlezun DJ, Sinyavskiy O, Peters N, Steigner L, Aksamit T, Girault MI, Garcia A, Gallagher C, Iliescu C. Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score. Medicina (Kaunas). 2022 Aug 3; 58 (8) Epub 2022 Aug 03
    View PubMed
  13. Henkle E, Brunton AE, Aksamit TR, Winthrop KL. Isolation of Pseudomonas aeruginosa after nontuberculous mycobacteria. Int J Tuberc Lung Dis. 2022 May 1; 26 (5):460-462
    View PubMed
  14. Chalmers SJ, Aksamit TR. New therapies for nontuberculous mycobacterial lung infection. Curr Opin Infect Dis. 2022 Apr 1; 35 (2):176-184
    View PubMed
  15. Metersky ML, Choate R, Aksamit TR, Conrad D, Lapinel NC, Maselli DJ, McShane PJ. Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry. Respir Med. 2022 Mar; 193:106746 Epub 2022 Jan 24
    View PubMed
  16. Aliberti S, Goeminne PC, O'Donnell AE, Aksamit TR, Al-Jahdali H, Barker AF, Blasi F, Boersma WG, Crichton ML, De Soyza A, Dimakou KE, Elborn SJ, Feldman C, Tiddens H, Haworth CS, Hill AT, Loebinger MR, Martinez-Garcia MA, Meerburg JJ, Menendez R, Morgan LC, Murris MS, Polverino E, Ringshausen FC, Shteinberg M, Sverzellati N, Tino G, Torres A, Vandendriessche T, Vendrell M, Welte T, Wilson R, Wong CA, Chalmers JD. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med. 2022 Mar; 10 (3):298-306 Epub 2021 Sept 24
    View PubMed
  17. Henkle E, Daley CL, Curtis JR, Chan B, Aksamit TR, Winthrop KL. Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis. ERJ Open Res. 2022 Jan; 8 (1) Epub 2022 Mar 07
    View PubMed
  18. Griffith DE, Thomson R, Flume PA, Aksamit TR, Field SK, Addrizzo-Harris DJ, Morimoto K, Hoefsloot W, Mange KC, Yuen DW, Ciesielska M, Wallace RJ Jr, van Ingen J, Brown-Elliott BA, Coulter C, Winthrop KL, CONVERT Study Group. Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term Exposure. Chest. 2021 Sep; 160 (3):831-842 Epub 2021 Apr 19
    View PubMed
  19. Maselli DJ, Yen A, Wang W, Okajima Y, Dolliver WR, Mercugliano C, Anzueto A, Restrepo MI, Aksamit TR, Basavaraj A, Aliberti S, Young KA, Kinney GL, Wells JM, San Jose Estepar R, Lynch DA, Diaz AA. Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort. Radiology. 2021 Sep; 300 (3):706-714 Epub 2021 June 22
    View PubMed
  20. McShane PJ, Philley JV, Prieto DA, Aksamit TR. Global Attitudes of Health Care Providers About Aerosolized Airway Clearance Therapy in Bronchiectasis Patients During the Coronavirus Disease 2019 Pandemic. Chronic Obstr Pulm Dis. 2021 Jul 28; 8 (3):319-325
    View PubMed
  21. Ku JH, Henkle EM, Aksamit TR, Winthrop KL. Limited Validity of Diagnosis Code-based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data. Ann Am Thorac Soc 2021 Jul; 18 (7):1246-1249
    View PubMed
  22. Pravosud V, Mannino DM, Prieto D, Zhang Q, Choate R, Malanga E, Aksamit TR. Symptom Burden and Medication Use Among Patients with Nontuberculous Mycobacterial Lung Disease. Chronic Obstr Pulm Dis. 2021 Apr 27; 8 (2):243-254
    View PubMed
  23. Griffith DE, Aksamit TR. Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend. Chest. 2021 Apr; 159 (4):1372-1381 Epub 2020 Oct 17
    View PubMed
  24. Flume PA, Griffith DE, Chalmers JD, Daley CL, Olivier K, O'Donnell A, Aksamit T, Kasperbauer S, Leitman A, Winthrop KL. Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration Workshop. Chest. 2021 Feb; 159 (2):537-543 Epub 2020 Aug 24
    View PubMed
  25. Choate R, Aksamit TR, Mannino D, Addrizzo-Harris D, Barker A, Basavaraj A, Daley CL, Daniels MLA, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, McShane PJ, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Stone G. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study. Respir Med. 2021 Feb; 177:106285 Epub 2020 Dec 24
    View PubMed
  26. Basavaraj A, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Daley CL, Anne Daniels ML, Eden E, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry. Chest. 2020 Oct; 158 (4):1376-1384 Epub 2020 July 03
    View PubMed
  27. Despotes KA, Choate R, Addrizzo-Harris D, Aksamit TR, Barker A, Basavaraj A, Daley CL, Eden E, DiMango A, Fennelly K, Philley J, Johnson MM, McShane PJ, Metersky ML, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Winthrop KL, Knowles MR, Daniels MLA, Noone PG. Nutrition and Markers of Disease Severity in Patients With Bronchiectasis. Chronic Obstr Pulm Dis. 2020 Oct; 7 (4):390-403
    View PubMed
  28. Martinez-Garcia MA, Aksamit TR, Agusti A. Clinical Fingerprinting: A Way to Address the Complexity and Heterogeneity of Bronchiectasis in Practice. Am J Respir Crit Care Med. 2020 Jan 1; 201 (1):14-19
    View PubMed
  29. Maglione M, Aksamit T, Santamaria F. Paediatric and adult bronchiectasis: Specific management with coexisting asthma, COPD, rheumatological disease and inflammatory bowel disease. Respirology. 2019 Nov; 24 (11):1063-1072 Epub 2019 June 20
    View PubMed
  30. Shteinberg M, Crossley B, Lavie T, Nadler S, Boyd J, Ringshausen FC, Aksamit T, Chalmers JD, Goeminne P. Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration. ERJ Open Res. 2019 Oct; 5 (4) Epub 2019 Oct 30
    View PubMed
  31. Henkle E, Curtis JR, Chen L, Chan B, Aksamit TR, Daley CL, Griffith DE, Winthrop KL. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Respir J. 2019 Jul; 54 (1) Epub 2019 July 18
    View PubMed
  32. Eden E, Choate R, Barker A, Addrizzo-Harris D, Aksamit TR, Daley CL, Daniels MLA, DiMango A, Fennelly K, Griffith DE, Johnson MM, Knowles MR, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Salathe MA, Schmid A, Thomashow B, Tino G, Turino GM, Winthrop KL. The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry. Chronic Obstr Pulm Dis. 2019 Apr 9; 6 (2):145-153 Epub 2019 Apr 09
    View PubMed
  33. Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL, CONVERT Study Group. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 Dec 15; 198(12):1559-1569.
    View PubMed
  34. Henkle E, Chan B, Curtis JR, Aksamit TR, Daley CL, Winthrop KL. Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014. Chest. 2018 Dec; 154 (6):1311-1320 Epub 2018 July 25
    View PubMed
  35. Griffith DE, Aksamit TR. Mycobacterium avium Complex and Bronchiectasis. There's Something Happening Here . . . Am J Respir Crit Care Med 2018 Nov 15; 198 (10):1252-1253
    View PubMed
  36. Henkle E, Aksamit TR, Daley CL, Griffith DE, O'Donnell AE, Quittner AL, Malanga E, Prieto D, Leitman A, Winthrop KL. US Patient-Centered Research Priorities and Roadmap for Bronchiectasis. Chest. 2018 Nov; 154 (5):1016-1023 Epub 2018 July 05
    View PubMed
  37. O'Donnell AE, Aksamit TR. 3rd World Bronchiectasis Conference. Chronic Obstr Pulm Dis. 2018 Oct 2; 5 (4):302-323 Epub 2018 Oct 02
    View PubMed
  38. Theel ES, Hilgart H, Breen-Lyles M, McCoy K, Flury R, Breeher LE, Wilson J, Sia IG, Whitaker JA, Clain J, Aksamit TR, Escalante P. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers. J Clin Microbiol. 2018 Jul; 56 (7) Epub 2018 June 25
    View PubMed
  39. Metersky ML, Aksamit TR, Barker A, Choate R, Daley CL, Daniels LA, DiMango A, Eden E, Griffith D, Johnson M, Knowles M, O'Donnell AE, Olivier K, Salathe M, Thomashow B, Tino G, Turino G, Winthrop KL, Mannino D. The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis Bronchiectasis. Ann Am Thorac Soc. 2018 Mar; 15 (3):365-370
    View PubMed
  40. van Ingen J, Aksamit T, Andrejak C, Bottger EC, Cambau E, Daley CL, Griffith DE, Guglielmetti L, Holland SM, Huitt GA, Koh WJ, Lange C, Leitman P, Marras TK, Morimoto K, Olivier KN, Santin M, Stout JE, Thomson R, Tortoli E, Wallace RJ Jr, Winthrop KL, Wagner D, for NTM-NET. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J 2018 Mar; 51 (3) Epub 2018 Mar 22
    View PubMed
  41. Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F, IRENE Network. The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol. Multidiscip Respir Med. 2018; 13 (Suppl 1):33 Epub 2018 Aug 09
    View PubMed
  42. De Soyza A, Aksamit T, Bandel TJ, Criollo M, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018 Jan; 51 (1) Epub 2018 Jan 25
    View PubMed
  43. Aksamit T, De Soyza A, Bandel TJ, Criollo M, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R. RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur Respir J. 2018 Jan; 51 (1) Epub 2018 Jan 25
    View PubMed
  44. Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017 Dec; 152 (6):1120-1127 Epub 2017 May 05
    View PubMed
  45. Aksamit T, Bandel TJ, Criollo M, De Soyza A, Elborn JS, Operschall E, Polverino E, Roth K, Winthrop KL, Wilson R. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis. Contemp Clin Trials. 2017 Jul; 58:78-85 Epub 2017 May 08
    View PubMed
  46. Ruffner MA, Aksamit TR, Thomashow B, Choate R, DiMango A, Turino GM, O'Donnell AE, Johnson MM, Olivier KN, Fennelly K, Daley CL, Winthrop KL, Metersky ML, Salathe MA, Knowles MR, Daniels MLA, Noone PG, Tino G, Griffith DE, Sullivan KE. Frequency of untreated hypogammaglobulinemia in bronchiectasis. Ann Allergy Asthma Immunol. 2017 Jul; 119 (1):83-85 Epub 2017 May 20
    View PubMed
  47. Hill AT, Haworth CS, Aliberti S, Barker A, Blasi F, Boersma W, Chalmers JD, De Soyza A, Dimakou K, Elborn JS, Feldman C, Flume P, Goeminne PC, Loebinger MR, Menendez R, Morgan L, Murris M, Polverino E, Quittner A, Ringshausen FC, Tino G, Torres A, Vendrell M, Welte T, Wilson R, Wong C, O'Donnell A, Aksamit T, EMBARC/BRR definitions working group. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017 Jun; 49 (6) Epub 2017 June 08
    View PubMed
  48. Aksamit TR, O'Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, Johnson M, Eden E, Griffith D, Knowles M, Metersky M, Salathe M, Thomashow B, Tino G, Turino G, Carretta B, Daley CL, Bronchiectasis Research Registry Consortium. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry. Chest. 2017 May; 151 (5):982-992 Epub 2016 Nov 23
    View PubMed
  49. Aliberti S, Dhar R, Aksamit TR, Morgan L, Chalmers JD. Additional important research priorities for bronchiectasis in China. Eur Respir J 2017 Jan; 49 (1) Epub 2017 Jan 18
    View PubMed
  50. Henkle E, Aksamit T, Barker A, Daley CL, Griffith D, Leitman P, Leitman A, Malanga E, Marras TK, Olivier KN, Prevots DR, Prieto D, Quittner AL, Skach W, Walsh JW, Winthrop KL, NTMRC Patient Advisory Panel. Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop Report. Ann Am Thorac Soc. 2016 Sep; 13 (9):S379-84
    View PubMed
  51. Wilson R, Aksamit T, Aliberti S, De Soyza A, Elborn JS, Goeminne P, Hill AT, Menendez R, Polverino E. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respir Med. 2016 Aug; 117:179-89 Epub 2016 June 07
    View PubMed
  52. De Soyza A, Aksamit T. Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis Expert Opinion on Orphan Drugs. 2016; 4: (8)875-84.
  53. Chalmers JD, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M, Dimakou K, Clifton I, van der Eerden M, Rohde G, Murris-Espin M, Masefield S, Gerada E, Shteinberg M, Ringshausen F, Haworth C, Boersma W, Rademacher J, Hill AT, Aksamit T, O'Donnell A, Morgan L, Milenkovic B, Tramma L, Neves J, Menendez R, Paggiaro P, Botnaru V, Skrgat S, Wilson R, Goeminne P, De Soyza A, Welte T, Torres A, Elborn JS, Blasi F. The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res. 2016 Jan; 2 (1) Epub 2016 Jan 20
    View PubMed
  54. Hamadah AM, Beaulieu LM, Wilson JW, Aksamit TR, Gregoire JR, Williams AW, Dillon JJ, Albright RC, Onuigbo M, Iyer VK, Hickson LJ. Tolerability and Healthcare Utilization in Maintenance Hemodialysis Patients Undergoing Treatment for Tuberculosis-Related Conditions. Nephron. 2016; 132 (3):198-206 Epub 2016 Feb 10
    View PubMed
  55. Griffith DE, Aksamit TR. Understanding nontuberculous mycobacterial lung disease: it's been a long time coming. F1000Res. 2016; 5:2797 Epub 2016 Nov 30
    View PubMed
  56. Philley JV, Wallace RJ Jr, Benwill JL, Taskar V, Brown-Elliott BA, Thakkar F, Aksamit TR, Griffith DE. Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. Chest. 2015 Aug; 148 (2):499-506
    View PubMed
  57. Wintrop KL, Ku JH, Marras TK, Griffith DE, Daley CL, Olivier KN, Aksamit TR, Mackey K, Prevots DR. The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease. Eur Respir J doi 101183/0903193600169114. 2015 Apr; 45(4):1177-9.
  58. Aksamit TR, Philley JV, Griffith DE. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respir Med. 2014 Mar; 108 (3):417-25 Epub 2013 Sept 25
    View PubMed
  59. Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Stuart Elborn J, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis: II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Annals of the American Thoracic Society. 2014; 11(8):1298-306.
    View PubMed
  60. Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis: I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Annals of the American Thoracic Society. 2014; 11(7):1120-9.
    View PubMed
  61. Moua T, Aksamit TR. Diagnosis and managment of nontuberculous mycobacterial lung infections. Current Respiratory Care Reports. 2014; 3:161-169.
  62. Sekiguchi H, Horie R, Aksamit TR, Yi ES, Ryu JH. Immunoglobulin G4-related disease mimicking asthma. Can Respir J. 2013 Mar-Apr; 20 (2):87-9
    View PubMed
  63. Griffith DE, Aksamit TR. Bronchiectasis and nontuberculous mycobacterial disease. Clin Chest Med. 2012 Jun; 33(2):283-95. Epub 2012 Apr 04.
    View PubMed
  64. Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, D'Ambrosio L, Centis R, Sotgiu G, Menegale O, Kliiman K, Aksamit T, Cirillo DM, Danilovits M, Dara M, Dheda K, Dinh-Xuan AT, Kluge H, Lange C, Leimane V, Loddenkemper R, Nicod LP, Raviglione MC, Spanevello A, Thomsen VO, Villar M, Wanlin M, Wedzicha JA, Zumla A, Blasi F, Huitric E, Sandgren A, Manissero D. European union standards for tuberculosis care. Eur Respir J. 2012 Apr; 39(4):807-19.
    View PubMed
  65. Griffith DE, Aksamit TR. Therapy of refractory nontuberculous mycobacterial lung disease. Curr Opin Infect Dis. 2012 Apr; 25(2):218-27.
    View PubMed
  66. van Ingen J, Griffith DE, Aksamit TR, Wagner D. Pulmonary diseases caused by non-tuberculous mycobacteria. European Respiratory Monograph. 2012; 58:25-37.
  67. Iyer VN, Joshi AY, Boyce TG, Brutinel MW, Scalcini MC, Wilson JW, McCoy K, Aksamit TR. Bronchoscopy in suspected pulmonary TB with negative induced-sputum smear and MTD((R)) Gen-probe testing. Respir Med. 2011 Jul; 105 (7):1084-90 Epub 2011 Mar 21
    View PubMed
  68. Khoury NZ, Binnicker MJ, Wengenack NL, Aksamit TR, Buchta WG, Molella RG. Preemployment screening for tuberculosis in a large health care setting: comparison of the tuberculin skin test and a whole-blood interferon-gamma release assay. J Occup Environ Med. 2011 Mar; 53(3):290-3.
    View PubMed
  69. Varkey P, Harris S, Edmonson L, McCoy K, Aksamit T, Brennan MD. An innovative model for tuberculosis control: an academic medical center-public health department partnership. Minn Med. 2010 Jan; 93(1):39-41.
    View PubMed
  70. Allam JS, Kennedy CC, Aksamit TR, Dispenzieri A. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Chest. 2008 Apr; 133 (4):969-74 Epub 2008 Jan 15
    View PubMed
  71. Gajic O, Afessa B, Hanson AC, Krpata T, Yilmaz M, Mohamed SF, Rabatin JT, Evenson LK, Aksamit TR, Peters SG, Hubmayr RD, Wylam ME. Effect of 24-hour mandatory versus on-demand critical care specialist presence on quality of care and family and provider satisfaction in the intensive care unit of a teaching hospital. Crit Care Med. 2008 Jan; 36 (1):36-44
    View PubMed
  72. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee//American Thoracic Society//Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15; 175 (4):367-416
    View PubMed
  73. Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006 Jun 1; 173(11):1283-9. Epub 2006 Mar 02.
    View PubMed
  74. Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH. Hot tub lung: presenting features and clinical course of 21 patients. Respir Med. 2006 Apr; 100(4):610-5. Epub 2005 Sep 27.
    View PubMed
  75. Kennedy CC, Aksamit TR. 33-year-old woman with pleuritic chest pain and nonproductive cough. Mayo Clin Proc. 2006 Jan; 81(1):85-8.
    View PubMed
  76. Afessa B, Kennedy CC, Klarich KW, Aksamit TR, Kolars JC, Hubmayr RD. Introduction of a 14-hour work shift model for housestaff in the medical ICU. Chest. 2005 Dec; 128 (6):3910-5
    View PubMed
  77. Festic E, Gajic O, Limper AH, Aksamit TR. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest. 2005 Aug; 128 (2):573-9
    View PubMed
  78. Jump SM, Sauver JL, Weaver AL, Bagniewski SM, Wilson JW, Huskins WC, Aksamit TR, Brutinel WM, Scalcini MC, Sia IG, Correa AG, McCoy K, Boyce TG. Incidence of tuberculosis in Olmsted County, Minnesota, 1990-2001. Mayo Clin Proc. 2004 Sep; 79(9):1119-23.
    View PubMed
  79. Aksamit TR. Hot tub lung: infection, inflammation, or both? Semin Respir Infect. 2003 Mar; 18(1):33-9.
    View PubMed
  80. Bunch TJ, Thalji MK, Pellikka PA, Aksamit TR. Respiratory failure in tetanus: case report and review of a 25-year experience. Chest. 2002 Oct; 122 (4):1488-92
    View PubMed
  81. Aksamit TR. Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin Chest Med. 2002 Sep; 23 (3):643-53
    View PubMed
  82. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc. 2001 Sep; 76(9):930-8.
    View PubMed
  83. Aksamit TR. Thromboembolism occurrence and diagnosis in the medical intensive care unit. Semin Thromb Hemost. 2001; 27 (1):47-57
    View PubMed
  84. Monick MM, Aksamit TR, Geist LJ, Hunninghake GW. Dexamethasone inhibits IL-1 and TNF activity in human lung fibroblasts without affecting IL-1 or TNF receptors. Am J Physiol. 1994 Jul; 267(1 Pt 1):L33-8.
    View PubMed
  85. Aksamit TR, Monick MM, Hunninghake GW. Protein kinase C modulates the amounts of IL-1 receptor mRNA in human lung fibroblasts. J Immunol. 1993 Jul 1; 151(1):284-90.
    View PubMed
  86. Aksamit TR, Hunninghake GW. Interleukin-1. Lung Biol Health Dis. 1992; 61:185-228.
  87. Aksamit T, Duggan C, Watson A, Pride NB. Use of oscillation methods to measure nasal airflow resistance. Eur Respir Rev. 1991; 1:232.
  88. Fitzsimons R, Grammer LC, Halwig JM, Aksamit T, Patterson R. Prevalence of adverse effects in corticosteroid dependent asthmatics. New England & Regional Allergy Proceedings. 1988 Mar-Apr; 9(2):157-62.
    View PubMed
  89. Aksamit TR, Floras JS, Victor RG, Aylward PE. Paroxysmal hypertension due to sinoaortic baroreceptor denervation in humans. Hypertension. 1987 Mar; 9(3):309-14.
    View PubMed
  90. Loeb JM, deTarnowsky JM, Aksamit TR. Effect of perfusion rate of cholinergic agonist on sinus node automaticity. J Electrocardiol. 1985 Jul; 18(3):287-94.
    View PubMed
PST-20217459